Blood test may predict rectal cancer remission without surgery
NCT ID NCT05629442
First seen Apr 24, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study looks at whether a simple blood test can detect genetic material from rectal cancer tumors (ctDNA) to predict if the cancer has fully responded to treatment. Researchers will follow 60 adults with non-spreading rectal cancer who receive standard chemotherapy and radiation. The goal is to see if ctDNA testing can help decide when it's safe to avoid surgery and monitor for cancer return more accurately than routine scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mass General Cancer Center Newton-Wellesley Hospital
Newton, Massachusetts, 02462, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.